These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
6. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]. Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656 [TBL] [Abstract][Full Text] [Related]
7. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Reddoch JM; Burke TW; Morris M; Tornos C; Levenback C; Gershenson DM Gynecol Oncol; 1995 Nov; 59(2):221-5. PubMed ID: 7590477 [TBL] [Abstract][Full Text] [Related]
9. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma]. Ma SK; Zhang HT; Wu LY; Liu LY; Li B Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701 [TBL] [Abstract][Full Text] [Related]
10. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate. Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483 [TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898 [TBL] [Abstract][Full Text] [Related]
12. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
13. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785 [TBL] [Abstract][Full Text] [Related]
14. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Rose PG; Sommers RM; Reale FR; Hunter RE; Fournier L; Nelson BE Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer. Kehoe SM; Zivanovic O; Ferguson SE; Barakat RR; Soslow RA Gynecol Oncol; 2010 May; 117(2):229-33. PubMed ID: 20199802 [TBL] [Abstract][Full Text] [Related]
16. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094 [TBL] [Abstract][Full Text] [Related]
17. Use of the sentinel node procedure to stage endometrial cancer. Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758 [TBL] [Abstract][Full Text] [Related]
18. The value of routine follow-up in patients treated for carcinoma of the vulva. Oonk MH; de Hullu JA; Hollema H; Mourits MJ; Pras E; Wymenga AN; van der Zee AG Cancer; 2003 Dec; 98(12):2624-9. PubMed ID: 14669281 [TBL] [Abstract][Full Text] [Related]